Trevi Therapeutics Inc. (TRVI) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-04-08
10:41 am
Purchase
2022-03-3013GTrevi Therapeutics, Inc.
TRVI
MAI Capital Management1,541,471
5.000%
1,541,471increase
(New Position)
Filing
History
2022-03-09
5:09 pm
Purchase
2022-02-2813GTrevi Therapeutics, Inc.
TRVI
Rosalind Advisors, Inc.2,185,664
8.500%
2,185,664increase
(New Position)
Filing
History
2022-03-09
11:18 am
Purchase
2022-03-0713GTrevi Therapeutics, Inc.
TRVI
Oliveira Steven Michael1,340,000
5.180%
1,340,000increase
(New Position)
Filing
History
2022-02-14
5:16 pm
Purchase
2021-12-3113GTrevi Therapeutics, Inc.
TRVI
Armistice Capital, LLC2,700,799
9.990%
2,700,799increase
(New Position)
Filing
History
2022-02-11
4:16 pm
Purchase
2022-01-1213GTrevi Therapeutics, Inc.
TRVI
TPG GP A, LLC4,824,883
18.700%
4,824,883increase
(New Position)
Filing
History
2022-01-26
4:15 pm
Unchanged
2021-12-3113GTrevi Therapeutics, Inc.
TRVI
Lundbeckfond Invest A/S 1,151,544
4.500%
0
(Unchanged)
Filing
History
2021-11-02
09:09 am
Purchase
2021-10-1813DTrevi Therapeutics, Inc.
TRVI
New Enterprise Associates 16, L.P.7,789,850
36.100%
1,851,852increase
(+31.19%)
Filing
History
2021-02-12
4:54 pm
Sale
2020-12-3113GTrevi Therapeutics, Inc.
TRVI
TPG Group Holdings (SBS) Advisors Inc.4,824,883
26.200%
-1,499,436decrease
(-23.71%)
Filing
History
Goto Prev, 0, 1, 2